Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights that the price adjustment by Laopu Gold exceeded expectations, reinforcing its high-end brand positioning. The price increase for most products ranged from 20% to 30%, significantly higher than previous adjustments [5][27] - The report emphasizes the shift in consumer demand towards self-wearing and aesthetic-driven purchases, suggesting that brands with differentiated product offerings are likely to navigate price increases more smoothly [31] Summary by Sections Industry Trends - The retail and social service indices reported a decline of 1.64% and an increase of 1.68% respectively during the week from February 24 to February 27, 2026. The retail index ranked 30th among 31 primary industries [7][16] - The jewelry sector has shown the highest growth, with a year-to-date increase of 10.59% [19] Investment Recommendations - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending Laopu Gold and Chaohongji, with beneficiaries including Liu Fu Group and Zhou Shengsheng [8][33] - Investment Theme 2: Highlighting retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket and Aiyingshi [8][33] - Investment Theme 3: Emphasizing beauty brands that meet emotional value and safety ingredient innovation, recommending Maogeping and Pola [8][33] - Investment Theme 4: Focusing on differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending Meilitiantian Medical Health and Aimeike [8][33] Company-Specific Insights - Laopu Gold reported a revenue of 12.354 billion yuan for the first half of FY2025, a year-on-year increase of 250.9%, with a net profit of 2.268 billion yuan, up 285.8% [35] - Chaohongji is expected to achieve a net profit of 436 to 533 million yuan in 2025, reflecting a growth of 125% to 175% [35] - Yonghui Supermarket is projected to have a net profit of -2.14 billion yuan in 2025, indicating a significant operational challenge [35] - Meilitiantian Medical Health anticipates a net profit growth of no less than 34% in 2025, showcasing strong resilience and potential for growth [43]

Core Viewpoint - The report indicates that Proya achieved a net profit attributable to shareholders of 1.03 billion yuan in Q1-Q3 2025, reflecting a 2.7% increase, although Q3 saw a decline of 23.6% in net profit to 230 million yuan, indicating slight pressure on performance [1] Financial Performance - Proya's net profit for Q1-Q3 2025 was 1.03 billion yuan, up 2.7% year-on-year [1] - In Q3 2025, the net profit dropped to 230 million yuan, down 23.6% compared to the previous year [1] Strategic Initiatives - The company continues to strengthen its "big single product strategy" and is upgrading core products while focusing on the development of new strategic products [1] - New product launches include the dual anti-aging eye cream 3.0, energy series 2.0, ruby mask 3.0, and a new ruby single-use product [1] Brand Development - Proya is pursuing a multi-brand and multi-category collaborative development strategy, with the innovative category brand "Original Color Pot" rapidly capturing market share in its niche [1] - The brand "Caitang" is focusing on the philosophy of "Chinese makeup, original beauty" to solidify its differentiated brand positioning [1] - The brand "Off&Relax" is deepening its penetration in the core shampoo category, enhancing its fragrance characteristics and therapeutic effects [1] Market Performance - During the Double Eleven shopping festival, Proya topped the Tmall sales chart within four hours, with GMV exceeding 460 million yuan in the first four hours of Li Jiaqi's beauty livestream [1] - The company is positioned as a leading domestic beauty brand, with a strong performance during Double Eleven and a reasonable valuation, maintaining a "buy" rating [1]

Core Insights - The company Proya has won the "IFSCC 2025 Top Ten Basic Research Award," becoming the only Chinese cosmetics company to receive this honor, highlighting the international recognition of China's beauty research capabilities [1][8] - Proya's research, conducted in collaboration with Zhejiang University, utilized AI-driven deep learning technology to efficiently screen bioactive compounds that enhance mitochondrial function and prevent skin aging [3][5] - The research led to the development of the anti-aging compound formula Cellergy pro™, which significantly improves energy metabolism in damaged cells and repairs mitochondrial abnormalities [3][5] Research and Development - Proya's research team, led by Dr. Wei Jihua, presented their findings at the IFSCC conference, showcasing a deep learning-aided screening platform that automates the analysis of mitochondrial dynamics and function [5] - The company has established collaborations with top institutions, including Zhejiang University and the University of Innsbruck, to explore mitochondrial function regulation and its relationship with aging pathways [6] - Proya aims to create original active ingredient screening models and develop high-quality self-researched raw materials, integrating advanced technologies into product development [6] Future Directions - The founder and chairman of Proya, Hou Junchen, emphasized the importance of scientific innovation and global research system investment as key drivers for the company's future [8] - Proya plans to continue its technology-driven and internationalization strategy to enhance its core competitiveness and promote high-quality development in Chinese beauty [8] - The Chief Scientific Officer, Huang Hu, noted that the award represents one of the highest accolades received by the Chinese research team in the history of IFSCC, reinforcing the commitment to empower Chinese brands on the global stage [8]